Three species of mosquito are of particular concern in Europe, according to the European Centre for Disease Prevention and ...

The reemergence of dengue virus serotype 3 (DENV-3) in Brazil after 17 years could help worsen fresh outbreaks of the disease ...

Researchers, led by those from Korea Advanced Institute of Science and Technology and the Institute for Basic Science, ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Researchers have unveiled new insights into how weather influences the spread of dengue fever. Their study identifies ...

NIH-funded clinical trial will evaluate new dengue therapeutic: Bethesda, Maryland Thursday, February 13, 2025, 11:00 Hrs [IST] A clinical trial supported by the National Institut ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

The research team led by KIM Jae Kyoung, Professor in the Department of Mathematical Sciences at KAIST and Chief Investigator ...

The illness typically lasts two to seven days, but severe cases can be deadly. An affected person will have flu-like symptoms ...

A study published in Science highlights how climate conditions, specifically rising temperatures and variations in rainfall, ...

New research has revealed insights into how weather influences the spread of dengue fever, identifying temperature and ...